Research Article from PubMed

Here’s a link to the journal article “Endocannabinoid System in the Airways” (posted December 2019) – which highlights the relationship between our Endocannabinoid System and how inflammation contibutes to blockage of the airways.

From the abstract:

“Cannabinoids and the mammalian endocannabinoid system is an important research area of interest and attracted many researchers because of their widespread biological effects. The significant immune-modulatory role of cannabinoids has suggested their therapeutic use in several inflammatory conditions. Airways are prone to environmental irritants and stimulants, and increased inflammation is an important process in most of the respiratory diseases. Therefore, the main strategies for treating airway diseases are suppression of inflammation and producing bronchodilation. The ability of cannabinoids to induce bronchodilation and modify inflammation indicates their importance for airway physiology and pathologies. In this review, the contribution of cannabinoids and the endocannabinoid system in the airways are discussed, and the existing data for their therapeutic use in airway diseases are presented.”

Cannabinoids are shown to be helpful for our endocannabinoid systems in regulating our body’s functions by inducing bronchodilation and reducing inflammation.

Leave a comment